Development of a predictive model for pancreatic cancer integrating serum metabolomics and polygenic risk score
Pancreatic cancer (PC) is highly aggressive and associated with extremely poor prognosis. Due to the lack of specfic symptoms in the early stage, most patients have already lost the opportunity for curative surgical resection at the time of diagnosis. Therefore, improving the early identification of individuals at...